Serina Therapeutics logo

Serina Therapeutics (SER) Q3 2024 Earnings

SER·Reported November 12, 2024·Before market open

Diluted EPS came in at $0.13.

Diluted EPS
$0.13
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q3 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q3 2024 Earnings FAQ

Common questions about Serina Therapeutics's Q3 2024 earnings report.

Serina Therapeutics (SER) reported Q3 2024 earnings on November 12, 2024 before market open.

Serina Therapeutics reported diluted EPS of $0.13 for Q3 2024.

You can read the 10-Q periodic report (0001708599-24-000026) directly on SEC EDGAR. The filing index links above go to sec.gov.